FGK Representative Service GmbH赞助的临床试验
总计12个结果
-
EsoCap AGFGK Clinical Research GmbH; FGK Representative Service B.V.完全的
-
Silence Therapeutics GmbHFGK Clinical Research GmbH; Granzer Regulatory Consulting & Services完全的
-
Pieris Pharmaceuticals GmbHFGK Clinical Research GmbH; Nuvisan Pharma Services; EUROCALIN Consortium完全的
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services终止
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services主动,不招人
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services完全的
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services终止
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services完全的
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services完全的
-
Dr. August Wolff GmbH & Co. KG ArzneimittelFGK Clinical Research GmbH; Nuvisan GmbH; Charles River Biopharmaceutical Services GmbH完全的
-
Medicines for Malaria VentureSanaria Inc.; Institute of Tropical Medicine, Belgium; Iqvia Pty Ltd; SGS Life Sciences, a division... 和其他合作者完全的
-
Medicines for Malaria VentureWashington University School of Medicine; Sanaria Inc.; Institute of Tropical Medicine, Belgium; SGS Life Sciences, a division of SGS Belgium NV 和其他合作者完全的